Middle-aged smokers have a higher risk of developing dementia

Published Date: 02 Mar 2023

Middle-aged smokers are more likely to report memory loss and confusion than non-smokers.

Read Full News

Latest News

What Drives 50-Day Neurology Wait Times? Not Just Supply

The average wait time for a first neurology appointment is nearly 50 days for commercially insured patients. The cause may not be what you think.

An Effective Alternative to ECT for Major Depression?

A newer brain stimulation therapy matched ECT for depression while causing less memory loss, offering a potential option for patients concerned about cognitive side effects.

Ibogaine: Federal Policy Push Meets Safety Concerns

Ibogaine is getting an accelerated federal research push, but the drug is unapproved and understudied and carries a documented risk for fatal cardiac arrhythmias.

Do Repetitive Motor Behaviors Always Signal Autism?

Repetitive motor behaviors such as hand flapping and rocking occur in more than one third of toddlers who do not meet diagnostic criteria for autism spectrum disorder.

Self-Administered Med Shows Promise in Myasthenia Gravis

Weekly subcutaneous gefurulimab delivered early is linked to lasting symptom improvement in patients with generalized myasthenia gravis in phase 3 PREVAIL trial.

Novel PD Drug May Delay Levodopa Initiation

Tavapadon may delay levodopa use in early Parkinson’s and help stabilize dosing in the later stages of the disease, with most patients avoiding initiation or dose increases.

Todays Updates

Baveno Criteria May Reduce Endoscopy Burden in Cirrhosis

The Baveno VI criteria show high sensitivity for ruling out clinically significant portal hypertension and high-risk varices in patients with cirrhosis.

Todays Updates

Baveno Criteria May Reduce Endoscopy Burden in Cirrhosis

The Baveno VI criteria show high sensitivity for ruling out clinically significant portal hypertension and high-risk varices in patients with cirrhosis.

Latest News

The average wait time for a first neurology appointment is nearly 50 days for commercially insured patients. The cause may not be what you think.

A newer brain stimulation therapy matched ECT for depression while causing less memory loss, offering a potential option for patients concerned about cognitive side effects.

Ibogaine is getting an accelerated federal research push, but the drug is unapproved and understudied and carries a documented risk for fatal cardiac arrhythmias.

Repetitive motor behaviors such as hand flapping and rocking occur in more than one third of toddlers who do not meet diagnostic criteria for autism spectrum disorder.

Weekly subcutaneous gefurulimab delivered early is linked to lasting symptom improvement in patients with generalized myasthenia gravis in phase 3 PREVAIL trial.

Tavapadon may delay levodopa use in early Parkinson’s and help stabilize dosing in the later stages of the disease, with most patients avoiding initiation or dose increases.

News All Time

FDA Seeks New Warning for Certain Parkinson's Drugs

The FDA said on Friday it has notified manufacturers of certain Parkinson's ⁠disease treatments to update their prescribing information with a...

Scottish Lawmakers Vote Against Allowing Assisted Dying

Scottish lawmakers have voted against legalising assisted, crushing hopes for a historic law change, ⁠as similar proposals in England and Wales also look set to fail.

Little Evidence of Cannabis Efficacy for Psychiatric Illness

A new review shows insufficient or low-quality evidence to suggest cannabinoids are effective at treating most psychiatric conditions and substance use disorders.

Prenatal Antiseizure Med Exposure: Risks Vary by Agent

A large cohort study sheds new light on neurodevelopmental risk in children after prenatal antiseizure medication exposure, with variation across individual agents.

Anxiety and Depression May Raise Risk for Aneurysm Rupture

Anxiety and depression are linked to an increased risk for rupture and mortality in patients with unruptured intracranial aneurysms, a new cohort study shows.

China Approves Market Launch Of Brain-computer Interface Medical Device in World First

China's drug regulator said on Friday that it has given the nod for a brain-computer interface (BCI) system ⁠that helps restore hand-movement ability to be sold, the world's...

Why Aren’t Canadians Getting Enough Sleep?

The change to daylight saving time and the marking of World Sleep Day call attention to the factors that contribute to sleep deficits among Canadians.

Single IV Ketamine Promising for Depression in MCI

Ketamine is well-tolerated in older adults with both mild cognitive impairment and depression and associated with improved depression scores, a new study shows.

Late Complications Common After CVT, Even After Recovery

Although a majority of patients with cerebral venous sinus thrombosis achieve independence, 1 in 3 may develop delayed complications such as seizures, a study shows.

Activity Trackers May Predict MS Progression

Reduced daytime physical activity, as measured with wearable trackers, is tied to increased risk for multiple sclerosis progression and brain atrophy, new research shows.

WHO Warns Of Health Risks From 'Black Rain' in Iran

The World Health Organization warned on Tuesday that the 'black rain' and toxic compounds in the air in Iran after strikes on ⁠oil facilities could cause respiratory problems.

Wildfire Smoke Tied to Higher Stroke Risk, Greater Severity

Short-term surges in air pollution from wildfire smoke have been linked to a greater incidence and severity of stroke.

Therapeutic Research in Alzheimer’s Disease: What Is New?

Long-term extension trial results with donanemab suggest a widening separation in cognitive decline through 36 months in early Alzheimer’s disease.

Reframing Dyslexia: Ancient Genes, Modern Skill

Study argues to move beyond ‘reading genes’ — focus on conserved neural-development networks in humans to improve early screening and identify therapeutic leads.

Adults With IDDs Face ‘Mental Health Crisis’

Adults with IDDs face disproportionately higher rates of anxiety and depression and barriers to care, prompting researchers to characterize the situation as a ‘mental health crisis.’

Smoking + Parkinson's: Lower Disease Risk, Higher Mortality

A large nationwide study revisits the smoking-Parkinson's paradox, linking current smoking to lower disease risk but linking quitting to lower all-cause mortality.

Recommended News For You

New guidelines expand access to lung cancer screening, but gaps remain in reaching rural and uninsured populations

High Fruit, Veggie Diet Tied to Early-Onset Lung Cancer?

A garden can save your life

Year in Review: Chronic Lymphocytic Leukemia

Video: Liver transplant for patients with advanced colorectal cancer

FDA Approves New Drug Combo for RR Multiple Myeloma

High weight and obesity are associated with poor outcomes in leukemia treatment.

Recommended Articles For You

MASLD and Cancer Risk: Pathogenic Links and Clinical Implications Reviewed 

Unveiling the Mystery of Echinocyte: A Closer Look at the Unique Red Blood Cell 

Paving the Path to Precision: A Review of TAR-200 in the Evolving Bladder Cancer Landscape 

Unlocking the Secrets of Hemoglobin: Exploring the Wonders of Life-Sustaining Iron Compounds 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Maintenance Rituximab Improves Survival in Elderly MRD-Negative MCL Patients.

2.

New PET tracer enables same-day imaging of triple-negative breast and urothelial cancers

3.

Intractable cancers may respond better to treatment when using new radiation and high-performance computing.

4.

In Higher-Risk MDS, CMML, All-Oral Therapy Has Promise.

5.

improvements in the treatment of prostate cancer resistant to chemotherapy.

1.

Exploring Digital Cognitive Stimulation for Elderly Breast Cancer Patients

2.

Survival Rate Dynamics in Hematologic and Solid Malignancies

3.

Essential Oncology Updates: Diagnosis, Treatment Advances, Tools & Education Resources

4.

Epigenetics and Resistance: Mechanisms in Histone Methylation-Targeted Therapies

5.

Cowden Syndrome and Cancer: Understanding the Risk Factors 

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part II

2.

Efficient Management of First line ALK-rearranged NSCLC - Part VII

3.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part IV

4.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VI

5.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part II

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot